Atlas Trials

A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus

Clinical trial NCT03338023 · COMPLETED

Trial details

NCT number
NCT03338023
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2018-03-23
Primary completion
2020-03-05
Enrollment
272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.